Rexahn Pharmaceuticals, Inc. To Present Data On RX-3117 And RX-21101 At The 2014 American Association for Cancer Research Annual Meeting

Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that it will have two poster presentations at the 2014 American Association for Cancer Research (AACR) Annual Meeting. The conference will take place in San Diego, California, on April 5-9, 2014 at the San Diego Convention Center.

Help employers find you! Check out all the jobs and post your resume.